Literature DB >> 27099866

New Clinical and Research Programs in Particle Beam Radiation Therapy: The University of California San Francisco Perspective.

Mack Roach1, Reinhard Schulte2, Kavita Mishra1, Bruce Faddegon1, Igor Barani1, Ann Lazar3, Eleanor A Blakely4.   

Abstract

Entities:  

Year:  2016        PMID： 27099866      PMCID： PMC4834449          DOI： 10.14338/IJPT-15-00025.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN： 2331-5180


× No keyword cloud information.
  8 in total

1.  How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.

Authors:  Andrea Peeters; Janneke P C Grutters; Madelon Pijls-Johannesma; Stefan Reimoser; Dirk De Ruysscher; Johan L Severens; Manuela A Joore; Philippe Lambin
Journal:  Radiother Oncol       Date:  2010-01-26       Impact factor: 6.280

2.  Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.

Authors:  Kavita K Mishra; Jeanne M Quivey; Inder K Daftari; Vivian Weinberg; Tia B Cole; Kishan Patel; Joseph R Castro; Theodore L Phillips; Devron H Char
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

Review 3.  Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience.

Authors:  Tadashi Kamada; Hirohiko Tsujii; Eleanor A Blakely; Jürgen Debus; Wilfried De Neve; Marco Durante; Oliver Jäkel; Ramona Mayer; Roberto Orecchia; Richard Pötter; Stanislav Vatnitsky; William T Chu
Journal:  Lancet Oncol       Date:  2015-02       Impact factor: 41.316

4.  High energy beams of radioactive nuclei and their biomedical applications.

Authors:  A Chatterjee; E L Alpen; C A Tobias; J Llacer; J Alonso
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-04       Impact factor: 7.038

5.  Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes.

Authors:  Arjun Sahgal; Michael W Chan; Eshetu G Atenafu; Laurence Masson-Cote; Gaurav Bahl; Eugene Yu; Barbara-Ann Millar; Caroline Chung; Charles Catton; Brian O'Sullivan; Jonathan C Irish; Ralph Gilbert; Gelareh Zadeh; Michael Cusimano; Fred Gentili; Normand J Laperriere
Journal:  Neuro Oncol       Date:  2014-12-27       Impact factor: 12.300

6.  Radiotherapy with heavy charged particles at Lawrence Berkeley Laboratory.

Authors:  J R Castro; J M Quivey; J T Lyman; G T Chen; T L Phillips; C A Tobias
Journal:  J Can Assoc Radiol       Date:  1980-03

7.  Treatment of cancer with heavy charged particles.

Authors:  J R Castro; W M Saunders; C A Tobias; G T Chen; S Curtis; J T Lyman; J M Collier; S Pitluck; K A Woodruff; E A Blakely; T Tenforde; D Char; T L Phillips; E L Alpen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-12       Impact factor: 7.038

8.  Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results.

Authors:  Matthias Uhl; Matthias Mattke; Thomas Welzel; Falk Roeder; Jan Oelmann; Gregor Habl; Alexandra Jensen; Malte Ellerbrock; Oliver Jäkel; Thomas Haberer; Klaus Herfarth; Jürgen Debus
Journal:  Cancer       Date:  2014-06-19       Impact factor: 6.860
  8 in total
  3 in total

Review 1.  Charged-particle therapy in cancer: clinical uses and future perspectives.

Authors:  Marco Durante; Roberto Orecchia; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

Review 2.  Clinical trials involving carbon-ion radiation therapy and the path forward.

Authors:  Ann A Lazar; Reinhard Schulte; Bruce Faddegon; Eleanor A Blakely; Mack Roach
Journal:  Cancer       Date:  2018-10-11       Impact factor: 6.860

3.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility.

Authors:  Eleanor A Blakely; Bruce Faddegon; Christopher Tinkle; Charles Bloch; Michael Dominello; Robert J Griffin; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.243
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.